The Bottom Line (Original Air Date: May 15, 2018) — Chris Gibson, Co-Founder and CEO of Recursion Pharmaceuticals. You may have heard of Recursion Pharmaceuticals in the media for its push to create 100 drug treatments in 10 years, focusing first on cures for rare diseases. The company’s approach is to combine drug repurposing efforts with artificial intelligence. In May of 2018, Chris sat down with Host Doug Wells to discuss this approach, and to delve deeper into the mission of Recursion Pharmaceuticals.
How do you feel about this topic?
Is there anything else you think we should know? We'd like to hear your thoughts. Send us your feedback using the form below.